Dec 07, 2020 / NTS GMT
Unidentified Analyst -
Hello, there. You're watching Proactive London. And joining us today, we have Lisa Anson here from Redx Pharma, the drug discovery and development company, focused on cancer and fibrosis. Hello to you, Lisa?
Lisa Mary Whewell Anson - Redx Pharma Plc - CEO & Executive Director
Hi, [Casey], nice to see you.
Questions and Answers:
Unidentified Analyst -Nice to see you. It's our first introduction here at Proactive, so plenty to discuss. But first of all, you've had a massive week because you've had this conditional raising of GBP 25.5 million. So I guess the question has to be, what are the plans now?
Lisa Mary Whewell Anson - Redx Pharma Plc - CEO & Executive Director
Yes. It's a very exciting announcement for us, the conditional raise that we announced this week and also the open offer. So this puts us in a much stronger financial position, which allows us really to drive forward our 2 key programs, 1 of which is in the clinic, 1 of which about to go into
Trustpilot
